P1124: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL EXPANSION PHASE: OUTCOMES BY BASELINE HISTOLOGY

• Neha Mehta-Shah,
• Eric Jacobsen,
• Pier Luigi Zinzani,
• Jasmine Zain,
• Monica Mead,
• Carla Casulo,
• Giuseppi Gritti,
• Lauren Pinter-Brown,
• Koji Izutsu,
• Sheila Waters,
• Jonathan Brammer,
• Barbara Pro,
• Steven Horwitz

Affiliations

Neha Mehta-Shah

1 Washington University School of Medicine in St. Louis, Saint Louis, United States

Eric Jacobsen

2 Dana-Farber Cancer Institute, Boston, United States

Pier Luigi Zinzani

3 Institute of Hematology Seràgnoli University of Bologna, Bologna, Italy

Jasmine Zain

4 City of Hope Medical Center, Duarte, United States

Monica Mead

5 UCLA Santa Monica Medical Center, Santa Monica, United States

Carla Casulo

6 University of Rochester, Rochester, United States

Giuseppi Gritti

7 ASST Papa Giovanni XXIII Hospital, Bergamo, Italy

Lauren Pinter-Brown

8 University of California Irvine, Irvine, United States

Koji Izutsu

9 National Cancer Center Hospital, Chuo City, Tokyo, Japan

Sheila Waters

10 Secura Bio, Inc., Las Vegas, United States

Jonathan Brammer

11 The Ohio State University, Columbus, United States

Barbara Pro

12 Columbia University Herbert Irving Medical Center, New York, United States

Steven Horwitz

13 Memorial Sloan Kettering Cancer Center New York, New York, United States